Johnson Financial Group, Inc. Gilead Sciences, Inc. Transaction History
Johnson Financial Group, Inc.
- $2.64 Billion
- Q3 2025
A detailed history of Johnson Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 18,790 shares of GILD stock, worth $2.35 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
18,790
Previous 22,645
17.02%
Holding current value
$2.35 Million
Previous $2.51 Million
16.93%
% of portfolio
0.08%
Previous 0.11%
Shares
33 transactions
Others Institutions Holding GILD
# of Institutions
2,378Shares Held
1.01BCall Options Held
10.4MPut Options Held
8.12M-
Black Rock Inc. New York, NY121MShares$15.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.9 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.39 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.65 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.77 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $157B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...